The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Venous thromboembolism and prognosis in cancer
Open accessAbstract
Venous thromboembolism (VTE) is a frequent complication of malignancy, and its incidence has increased markedly in recent years. VTE itself can directly lead to patient mortality, and is the second leading cause of death in patients with cancer. Furthermore, emerging data suggest that activation of coagulation in malignancy is integrally linked with tumor biology, particularly with angiogenesis. The development of the clinical hypercoagulable state is also linked with adverse prognosis in patients with cancer, including patients receiving systemic chemotherapy. This review focuses on the clinical evidence documenting a link between VTE and adverse short-term and long-term prognosis in patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and validation of a predictive model for chemotherapy-associated thrombosis
Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H., & Francis, C. W. (2008) · Blood · doi:10.1182/blood-2007-10-116327 · Cited by 2,217
Self-citationKabbinavar, F., Hurwitz, H. I., Fehrenbacher, L., Meropol, N. J., Novotny, W. F., Lieberman, G., Griffing, S., & Bergsland, E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.066 · Cited by 1,716
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
KHORANA, A. A., FRANCIS, C. W., CULAKOVA, E., KUDERER, N. M., & LYMAN, G. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02374.x · Cited by 1,670
Self-citationPrognosis of Cancers Associated with Venous Thromboembolism
Sørensen, H. T., Mellemkjær, L., Olsen, J. H., & Baron, J. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432504 · Cited by 1,628
Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common Cancers
Chew, H. K., Wun, T., Harvey, D. J., Zhou, H., & White, R. H. R. (2006) · Archives of Internal Medicine · doi:10.1001/.458 · Cited by 1,321
Heit, J. A., O'Fallon, W. M., Petterson, T. M., Lohse, C. M., Silverstein, M. D., Mohr, D. N., & Melton, L. J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.11.1245 · Cited by 1,104
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M., & Lyman, G. H. (2007) · Cancer · doi:10.1002/cncr.23062 · Cited by 781
Self-citationThe Hypercoagulable State of Malignancy: Pathogenesis and Current Debate
Caine, G. J., Stonelake, P. S., Lip, G. Y. H., & Kehoe, S. T. (2002) · Neoplasia · doi:10.1038/sj.neo.7900263 · Cited by 576
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Gomez, M. L., Gomez‐Raposo, C., & Lobo Samper, F. (2008) · Cancer · doi:10.1002/cncr.23524 · Cited by 549
Thromboembolism in Hospitalized Neutropenic Cancer Patients
Khorana, A. A., Francis, C. W., Culakova, E., Fisher, R. I., Kuderer, N. M., & Lyman, G. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8877 · Cited by 475
Self-citationTissue Factor, Thrombin, and Cancer
Rickles, F. R., Patierno, S., & Fernandez, P. M. (2003) · Chest · doi:10.1378/chest.124.3_suppl.58s · Cited by 378
Venous Thromboembolism in Patients With Colorectal Cancer: Incidence and Effect on Survival
Alcalay, A., Wun, T., Khatri, V., Chew, H. K., Harvey, D., Zhou, H., & White, R. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2150 · Cited by 365
The Hemostatic System as a Regulator of Angiogenesis
Browder, T., Folkman, J., & Pirie-Shepherd, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1521 · Cited by 316
The incidence of venous thromboembolism among patients with primary lung cancer
CHEW, H. K., DAVIES, A. M., WUN, T., HARVEY, D., ZHOU, H., & WHITE, R. H. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02908.x · Cited by 291
Incidence of Venous Thromboembolism and the Impact on Survival in Breast Cancer Patients
Chew, H. K., Wun, T., Harvey, D. J., Zhou, H., & White, R. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.4393 · Cited by 278
Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival
Kuderer, N. M., Ortel, T. L., & Francis, C. W. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.4584 · Cited by 216
Ku, G. H., White, R. H., Chew, H. K., Harvey, D. J., Zhou, H., & Wun, T. (2009) · Blood · doi:10.1182/blood-2008-08-175745 · Cited by 193
Prognostic Significance of Tissue Factor in Pancreatic Ductal Adenocarcinoma
Nitori, N., Ino, Y., Nakanishi, Y., Yamada, T., Honda, K., Yanagihara, K., Kosuge, T., Kanai, Y., Kitajima, M., & Hirohashi, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0866 · Cited by 174
Malignancy, thrombosis and Trousseau: the case for an eponym
Khorana, A. A. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2003.00501.x · Cited by 166
Self-citationCavo, M., Zamagni, E., Cellini, C., Tosi, P., Cangini, D., Cini, M., Valdré, L., Palareti, G., Masini, L., Tura, S., et al. (2002) · Blood · doi:10.1182/blood-2002-06-1674 · Cited by 152
Kuenen, B. C., Levi, M. M., Meijers, J. C. M., van Hinsbergh, V. W. M., Berkhof, J. H., Kakkar, A. K., Hoekman, K., & Pinedo, H. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.046 · Cited by 124
Thalidomide and Deep Vein Thrombosis in Multiple Myeloma: Risk Factors and Effect on Survival
Zangari, M., Barlogie, B., Thertulien, R., Jacobson, J. L., Eddleman, P., Fink, L. M., Fassas, A., van Rhee, F., Talamo, G., Lee, C.-K., et al. (2003) · Clinical Lymphoma · doi:10.3816/clm.2003.n.011 · Cited by 112
Venous thromboembolism in patients with diffuse large B-cell lymphoma
Komrokji, R. S., Uppal, N., Khorana, A. A., Lyman, G. H., Kaplan, K. L., Fisher, R. I., & Francis, C. W. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600560991 · Cited by 86
Self-citationHan, L. Y., Landen, C. N., Kamat, A. A., López, A., Bender, D., Mueller, P., Schmandt, R. E., Gershenson, D. M., & Sood, A. K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9181 · Cited by 71
The Impact of Venous Thromboembolism on Risk of Death or Hemorrhage in Older Cancer Patients
Gross, C. P., Galusha, D. H., & Krumholz, H. M. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0019-x · Cited by 49
Venous thromboembolism and all-cause mortality in cancer patients receiving chemotherapy
Kuderer, N. M., Francis, C. W., Culakova, E., Khorana, A. A., Ortel, T. L., Falanga, A., & Lyman, G. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.9521 · Cited by 31
Self-citation
Cited by
Exosome-Mediated Metastasis: Communication from a Distance
Wortzel, I., Dror, S., Kenific, C. M., & Lyden, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.011 · Cited by 1,285
Brahmer, J. R., Abu-Sbeih, H., Ascierto, P. A., Brufsky, J., Cappelli, L. C., Cortazar, F. B., Gerber, D. E., Hamad, L., Hansen, E., Johnson, D. B., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002435 · Cited by 917
New insights into the mechanisms of venous thrombosis
Mackman, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60229 · Cited by 436
Balaban, E. P., Mangu, P. B., Khorana, A. A., Shah, M. A., Mukherjee, S., Crane, C. H., Javle, M. M., Eads, J. R., Allen, P., Ko, A. H., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.5561 · Cited by 381
Self-citationKhorana, A. A., Mangu, P. B., Berlin, J., Engebretson, A., Hong, T. S., Maitra, A., Mohile, S. G., Mumber, M., Schulick, R., Shapiro, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.5553 · Cited by 366
Self-citation
Metadata
- Authors
- Khorana, A. A.
- Venue
- Thrombosis Research
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 125
- Issue
- 6
- Pages
- 490-493
- ISSN
- 0049-3848 (ISSN-L)
- OpenAlex
- W2059152519
- Cited by
- 410
- References
- 26
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.